Ureaplasma urealyticum

Ureaplasma urealyticum is a bacterium commonly found in the genitourinary tract, and if not identified and treated in time, it can lead to various health problems. Early diagnosis and treatment help in managing the infection and preventing complications. If you suspect an infection or need more information about testing, you can schedule an analysis at IntroLab in Belgrade, where specialists use advanced methods for accurate testing and diagnosis.

When is Ureaplasma Urealyticum testing recommended?

Testing for Ureaplasma urealyticum is recommended when there is a strong suspicion of infection, or if an individual exhibits symptoms typically associated with genitourinary infections.

Ureaplasma urealyticum is a bacterium frequently found in the human genitourinary system. While it may remain asymptomatic in many cases, it can lead to significant health problems if left untreated.

What are the symptoms of Ureaplasma?

Ureaplasma urealyticum can be present in the genitourinary tract without causing symptoms. However, when symptoms do occur, they may include:

• Burning or pain during urination.
• Increased need to urinate.
• Urethritis (inflammation of the urethra).
• Pain in the lower abdomen or pelvis.
• Unusual vaginal discharge.
• Infertility.

In pregnant women, an Ureaplasma urealyticum infection can also be associated with preterm birth and low birth weight of the newborn.

How is Ureaplasma transmitted?

Ureaplasma urealyticum is most commonly transmitted through sexual contact, including unprotected vaginal, anal, or oral sex. Practicing safe sex is essential to reduce the risk of transmission. In addition to sexual transmission, vertical transmission is possible, meaning the bacteria can be passed from mother to child during childbirth. However, not everyone exposed to the bacteria will necessarily develop symptoms or become infected. Nevertheless, proper prevention is key to protecting against potential infections.

What complications can arise if the infection is untreated?

Ureaplasma is a common cause of non-gonococcal and non-chlamydial urethritis. It is also suspected that Ureaplasma may be associated with more serious conditions, such as kidney inflammation, known as pyelonephritis, or Reiter’s syndrome. Additionally, Ureaplasma has been linked to pneumonia, particularly in individuals with compromised immune systems.

How is the infection diagnosed?

The diagnosis of Ureaplasma urealyticum infection is based on laboratory testing. Two primary techniques are commonly used to detect this bacterium:

• Culture and Identification: Swabs, either from the cervix in women or the urethra in men, are placed in specialized nutrient media to encourage bacterial growth. Once cultured, the bacteria are identified through microscopic inspection and other laboratory procedures.
• PCR Analysis: This technique uses polymerase chain reaction (PCR) to detect Ureaplasma DNA in the samples. Due to its high sensitivity, PCR can identify even very small amounts of bacterial DNA, making it an extremely accurate diagnostic method.

What samples are used for diagnosis?

For accurate laboratory diagnosis, the following samples are typically used:

• Cervical swab for women.
• Urethral swab for men.
• Semen sample.
• First-morning urine sample, for both genders.

How is Ureaplasma treated?

Treating Ureaplasma can be challenging due to the bacteria’s unique characteristic of lacking a cell wall. While most antibiotics target the cell wall, treating Ureaplasma requires careful selection of specific antibiotics. Based on a detailed antibiotic sensitivity test (antibiogram), the appropriate specialized antibiotic is prescribed for treatment. It’s important to note that both partners should undergo treatment to minimize the risk of reinfection. Special care must be taken for pregnant women, ensuring that medications chosen are safe for both the mother and the baby.